Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro

Biochemistry

Volumn 48, Issue 51, 2009, Pages 12290-12297

  LaPointe, Nichole E ^a   Horowitz, Peleg M ^a   Guillozet Bongaarts, Angela L ^a   Silva, Andres ^a   Andreadis, Athena ^c   Binder, Lester I ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT BRAIN; ALTERNATIVE SPLICING; ALZHEIMER'S DISEASE; C-TERMINAL TAIL; DISEASE PROGRESSION; ENDOGENOUS INHIBITOR; FILAMENT FORMATION; FULL-LENGTH PROTEINS; IN-VITRO; INHIBITORY ACTIVITY; INTRACELLULAR ACCUMULATION; ISOFORMS; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULES; N-TERMINALS; NATURALLY OCCURRING; TAUOPATHIES; TYROSINE PHOSPHORYLATION;

FILAMENTS (LAMP); ORGANIC ACIDS; PHOSPHATASES; PHOSPHORYLATION; POLYMERIZATION; PROTEINS;

AMINO ACIDS;

PROLINE; TAU PROTEIN; TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; DISEASE COURSE; EXON; IN VITRO STUDY; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN FOLDING; PROTEIN ISOFORMS; TAU PROTEINS;

EID: 73149118023     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi901304u     Document Type: Article

References (48)

1. Binder, L. I., Guillozet-Bongaarts, A. L., Garcia-Sierra, F., and Berry, R. W. (2005) Tau, tangles, and Alzheimer's disease. Biochim. Biophys. Acta 1739, 216-223.
2. Braak, H., and Braak, E. (1985) On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol. 68, 325-332.
3. Mesulam, M. M. (1999) Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 24, 521-529.
4. Guillozet, A. L., Weintraub, S., Mash, D. C., and Mesulam, M. M. (2003) Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch. Neurol. 60, 729-736.
5. Horowitz, P. M., LaPointe, N., Guillozet-Bongaarts, A. L., Berry, R. W., and Binder, L. I. (2006) N-terminal fragments of tau inhibit full-length tau polymerization in vitro. Biochemistry 45, 12859-12866.
6. Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H. J., and Mandelkow, E. (2006) Global hairpin folding of tau in solution. Biochemistry 45, 2283-2293.
7. Mukrasch, M. D., Bibow, S., Korukottu, J., Jeganathan, S., Biernat, J., Griesinger, C., Mandelkow, E., and Zweckstetter, M. (2009) Structural polymorphism of 441-residue tau at single residue resolution. PLoS Biol. 7, e34.
8. Berry, R. W., Abraha, A., Lagalwar, S., LaPointe, N., Gamblin, T. C., Cryns, V. L., and Binder, L. I. (2003) Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. Biochemistry 42,8325-8331.
9. Andreadis, A. (2005) Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta 1739, 91-103.
10. Luo, M. H., Leski, M. L., and Andreadis, A. (2004) Tau isoforms which contain the domain encoded by exon 6 and their role in neurite elongation. J. Cell. Biochem. 91, 880-895.
11. Wei, M. L., and Andreadis, A. (1998) Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau. J. Neurochem. 70, 1346-1356.
12. Wei, M. L., Memmott, J., Screaton, G., and Andreadis,A. (2000) The splicing determinants of a regulated exon in the axonal MAP tau reside within the exon and in its upstream intron. Brain Res. Mol. Brain Res. 80, 207-218.
13. Goode, B. L., and Feinstein, S. C. (1994) Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. J. Cell Biol. 124, 769-782.
14. Goode, B. L., Denis, P. E., Panda, D., Radeke, M. J., Miller, H. P., Wilson, L., and Feinstein, S. C. (1997) Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly. Mol. Biol. Cell 8, 353-365.
15. Mukrasch, M. D., von Bergen, M., Biernat, J., Fischer, D., Griesinger, C., Mandelkow, E., and Zweckstetter, M. (2007) The "jaws" of the tau-microtubule interaction. J. Biol. Chem. 282, 12230-12239.
16. Abraha, A., Ghoshal, N., Gamblin, T. C., Cryns, V., Berry, R. W., Kuret, J., and Binder, L. I. (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J. Cell Sci. 113 (Part 21), 3737-3745.
17. von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E. M., and Mandelkow, E. (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc. Natl. Acad. Sci. U.S.A. 97, 5129-5134.
18. Wang, J., Tse, S. W., and Andreadis,A. (2007) Tau exon 6 is regulated by an intricate interplay of trans factors and cis elements, including multiple branch points. J. Neurochem. 100, 437-445.
19. Luo, M. H., Tse, S. W., Memmott, J., and Andreadis, A. (2004) Novel isoforms of tau that lack the microtubule-binding domain. J. Neurochem. 90, 340-351.
20. King, M. E., Ahuja, V., Binder, L. I., and Kuret, J. (1999) Liganddependent tau filament formation: implications for Alzheimer's disease progression. Biochemistry 38, 14851-14859.
21. Gamblin, T. C., King, M. E., Dawson, H., Vitek, M. P., Kuret, J., Berry, R. W., and Binder, L. I. (2000) In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. Biochemistry 39, 6136-6144.
22. Carmel, G., Mager, E. M., Binder, L. I., and Kuret, J. (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271, 32789-32795.
23. King, M. E., Gamblin, T. C., Kuret, J., and Binder, L. I. (2000) Differential assembly of human tau isoforms in the presence of arachidonic acid. J. Neurochem. 74, 1749-1757.
24. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. Ghoshal, N., Garcia-Sierra, F., Wuu, J., Leurgans, S., Bennett, D. A., Berry, R. W., and Binder, L. I. (2002) Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp. Neurol. 177, 475-493.
26. Lebouvier, T., Scales, T. M., Williamson, R., Noble, W., Duyckaerts, C., Hanger,D. P., Reynolds, C. H.,Anderton, B. H., and Derkinderen, P. (2009) The microtubule-associated protein tau is also phosphorylated on tyrosine. J. Alzheimer's Dis. 18, 1-9.
27. Huang, W., and Erikson, R. L. (1994) Constitutive activation of Mek1 by mutation of serine phosphorylation sites. Proc. Natl. Acad. Sci. U.S.A. 91, 8960-8963.
28. Leroy, O., Wang, J., Maurage, C. A., Parent, M., Cooper, T., Buee, L., Sergeant, N., Andreadis, A., and Caillet-Boudin, M. L. (2006) Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1. Biochim. Biophys. Acta 1762, 460-467.
29. Brandt, R., Leger, J., and Lee, G. (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131, 1327-1340.
30. Lee, V. M., Goedert, M., and Trojanowski, J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
31. Piao, Y. S., Hayashi, S., Wakabayashi, K., Kakita, A., Aida, I., Yamada, M., and Takahashi, H. (2002) Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 103, 469-474.
32. Lee, G., Thangavel, R., Sharma, V. M., Litersky, J. M., Bhaskar, K., Fang, S. M., Do, L. H., Andreadis, A., Van Hoesen, G., and Ksiezak-Reding, H. (2004) Phosphorylation of tau by fyn: implications for Alzheimer's disease. J. Neurosci. 24, 2304-2312.
33. Vega, I. E., Cui, L., Propst, J. A., Hutton, M. L., Lee, G., and Yen, S. H. (2005) Increase in tau tyrosine phosphorylation correlateswith the formation of tau aggregates. Brain Res. Mol. Brain Res. 138, 135-144.
34. Bhaskar, K., Yen, S. H., and Lee, G. (2005) Disease-related modifications in tau affect the interaction between Fyn and Tau. J. Biol. Chem. 280, 35119-35125.
35. Lee, G., Newman, S. T., Gard, D. L., Band, H., and Panchamoorthy, G. (1998) Tau interacts with src-family non-receptor tyrosine kinases. J. Cell Sci. 111 (Part 21), 3167-3177.
36. Reyes, J. F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Guillozet-Bongaarts, A. L., Berry, R., and Binder, L. I. (2008) A possible link between astrocyte activation and tau nitration in Alzheimer's disease. Neurobiol. Dis. 31, 198-208.
37. Reynolds, M. R., Reyes, J. F., Fu, Y., Bigio, E. H., Guillozet-Bongaarts, A. L., Berry, R. W., and Binder, L. I. (2006) Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies. J. Neurosci. 26, 10636-10645.
38. Poorkaj, P., Muma, N. A., Zhukareva, V., Cochran, E. J., Shannon, K. M.,Hurtig, H.,Koller, W. C., Bird, T. D., Trojanowski, J.Q., Lee, V. M., and Schellenberg, G. D. (2002) An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol. 52, 511-516.
39. Hayashi, S., Toyoshima,Y., Hasegawa,M.,Umeda,Y.,Wakabayashi, K., Tokiguchi, S., Iwatsubo, T., and Takahashi, H. (2002) Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann. Neurol. 51, 525-530.
40. Horowitz, P. M., Patterson, K. R., Guillozet-Bongaarts, A. L., Reynolds, M. R., Carroll, C. A., Weintraub, S. T., Bennett, D. A., Cryns, V. L., Berry, R. W., and Binder, L. I. (2004) Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci. 24, 7895-7902.
41. Sengupta, S., Horowitz, P. M., Karsten, S. L., Jackson, G. R., Geschwind, D. H., Fu, Y., Berry, R. W., and Binder, L. I. (2006) Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro. Biochemistry 45, 15111-15119.
42. LaPointe, N. E., Morfini, G., Pigino, G., Gaisina, I. N., Kozikowski, A. P., Binder, L. I., and Brady, S. T. (2009) The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J. Neurosci. Res. 87, 440-451.
43. King, M. E., Kan, H. M., Baas, P. W., Erisir, A., Glabe, C. G., and Bloom, G. S. (2006) Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid. J. Cell Biol. 175, 541-546.
44. Barbato,C.,Canu, N.,Zambrano,N., Serafino, A.,Minopoli,G.,Ciotti, M. T., Amadoro, G., Russo, T., and Calissano, P. (2005) Interaction of tau with Fe65 links tau to APP. Neurobiol. Dis. 18, 399-408.
45. Williamson, R., Scales, T., Clark, B. R., Gibb, G., Reynolds, C. H., Kellie, S., Bird, I. N., Varndell, I. M., Sheppard, P. W., Everall, I., and Anderton, B. H. (2002) Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J. Neurosci. 22, 10-20.
46. Hernandez, P., Lee, G., Sjoberg, M., and Maccioni, R. B. (2009) Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts. J. Alzheimer's Dis. 16,149-156.
47. Amadoro, G., Serafino, A. L., Barbato, C., Ciotti, M. T., Sacco, A., Calissano, P., and Canu, N. (2004) Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cell Death Differ. 11, 217-230.
48. Amadoro, G., Ciotti, M. T., Costanzi, M., Cestari, V., Calissano, P., and Canu, N. (2006) NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc. Natl. Acad. Sci. U.S.A. 103, 2892-2897.